During the past decade, Baylor Research Institute - Dermatology Research conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Baylor Research Institute - Dermatology Research" are "Plaque Psoriasis" (2 trials) and "Psoriasis" (1 trials). Many other conditions were trialed in "Baylor Research Institute - Dermatology Research" in a lesser frequency.

Most popular intervention types in "Baylor Research Institute - Dermatology Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Clobex® Spray morning and Vectical™ Ointment evening regimen" (1 trials), "Vectical™ Ointment weekdays and Clobex® Spray weekends regimen" (1 trials), "clobetasol propionate ointment" (1 trials) and "clobetasol propionate spray" (1 trials). Other intervention names were less common.

The vast majority of trials in "Baylor Research Institute - Dermatology Research" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Baylor Research Institute - Dermatology Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Baylor Research Institute - Dermatology Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Baylor Research Institute - Dermatology Research, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".